Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Biomarker Research|June 16, 2020
Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemiaDesiree Kunadt, Michael Kramer, Claudia Dill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemiaMartin Bornhäuser, Thomas Illmer, Uta Oelschlaegel, et al.
Transplantation|October 24, 2014
Pretransplant metabolic distress predicts relapse of acute myeloid leukemia after allogeneic stem cell transplantationSascha Dietrich, Aleksandar Radujkovic, Friedrich Stölzel, et al.
Experimental Hematology|July 26, 2011
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemiaDmitriy Ovcharenko, Friedrich Stölzel, David Poitz, et al.
Haematologica|May 13, 2008
Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemiaDorle Messerer, Jutta Engel, Joerg Hasford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemiaTilmann Bochtler, Friedrich Stölzel, Christoph E Heilig, et al.
British Journal of Haematology|February 26, 2013
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemiaBrigitte Mohr, Johannes Schetelig, Kerstin Schäfer-Eckart, et al.
Pageof 9